IRIS
SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.006
AS - Asia 1.296
EU - Europa 658
SA - Sud America 363
AF - Africa 39
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.943
SG - Singapore 376
BR - Brasile 286
IT - Italia 248
CN - Cina 197
HK - Hong Kong 195
BD - Bangladesh 178
TR - Turchia 138
IE - Irlanda 131
VN - Vietnam 92
FR - Francia 69
DE - Germania 57
GB - Regno Unito 38
CA - Canada 29
AR - Argentina 28
NL - Olanda 26
MX - Messico 25
IN - India 23
PL - Polonia 20
EC - Ecuador 18
ZA - Sudafrica 16
AT - Austria 14
FI - Finlandia 12
ID - Indonesia 12
IQ - Iraq 12
CO - Colombia 11
IL - Israele 10
PY - Paraguay 8
SA - Arabia Saudita 8
SE - Svezia 8
PK - Pakistan 7
AU - Australia 6
JP - Giappone 6
MA - Marocco 6
UZ - Uzbekistan 6
EG - Egitto 5
GR - Grecia 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
MY - Malesia 4
RU - Federazione Russa 4
TN - Tunisia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ES - Italia 3
KE - Kenya 3
LB - Libano 3
NP - Nepal 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
LV - Lettonia 2
PA - Panama 2
TH - Thailandia 2
UA - Ucraina 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.370
Salva come PNG Salva come JPEG
Città #
Dallas 901
San Jose 197
Hong Kong 191
Singapore 158
Dublin 131
Ashburn 130
The Dalles 95
Istanbul 66
Beijing 61
Boardman 61
Chicago 58
Santa Clara 50
Ankara 43
New York 43
Los Angeles 40
Ho Chi Minh City 32
São Paulo 24
Rome 23
Hanoi 21
Frankfurt am Main 18
Hillsboro 17
Warsaw 17
Milan 14
Naples 14
Amsterdam 13
Council Bluffs 13
Munich 13
Mexico City 12
Rio de Janeiro 12
Buffalo 10
Chennai 10
Helsinki 10
Rimini 10
San Francisco 10
Vienna 9
Brasília 8
Paris 8
York 8
Haiphong 7
Johannesburg 7
Mishmar HaShiv`a 7
Assago 6
Bologna 6
Brooklyn 6
Bursa 6
Catania 6
Curitiba 6
Fortaleza 6
Nuremberg 6
Orem 6
Reston 6
Stockholm 6
Tashkent 6
Athens 5
Düsseldorf 5
Guangzhou 5
Guayaquil 5
Limburg an der Lahn 5
Nijmegen 5
Quito 5
Recife 5
Seattle 5
Toronto 5
Belo Horizonte 4
Boston 4
Cairo 4
Divinópolis 4
Florence 4
London 4
Palermo 4
Pasadena 4
Riccione 4
Seoul 4
Sydney 4
Thái Bình 4
Turin 4
Verona 4
Asunción 3
Biên Hòa 3
Brescia 3
Brno 3
Buenos Aires 3
Campo Grande 3
City of London 3
Dammam 3
Denizli 3
Denver 3
Dhaka 3
Erbil 3
Ferrara 3
Goiânia 3
Hangzhou 3
Lauterbourg 3
Lima 3
Lyon 3
Manchester 3
Modena 3
New Delhi 3
Ottawa 3
Petrópolis 3
Totale 2.819
Salva come PNG Salva come JPEG
Nome #
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 581
Understanding and treating postpartum depression: a narrative review 101
A comprehensive overview of post-stroke depression treatment options 95
Depression: Understanding and Managing Antidepressant Side Effects 95
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors 91
Resistance to Change from a Psychological Perspective 83
Expanding treatment domains across psychiatric disorders 81
Treatment-Resistant Depression: When and How Should It Be Referred? 80
Neurological, Metabolic, and Psychopathological Correlates of Lifetime Suicidal Behaviour in Major Depressive Disorder without Current Suicide Ideation 79
Suicide ideation and male-female differences in major depressive disorder 76
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 75
Anhedonia: Current and future treatments 74
Exploring the use of immunomethylomics in the characterization of depressed patients: A proof-of-concept study 73
Mental fatigue in individuals with psychiatric disorders: a scoping review 71
Anhedonia and Depressive Disorders 71
Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance 71
A Clinically Oriented Review of New Antipsychotics for Schizophrenia 70
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence 68
[Assisted suicide for patients suffering from severe depression. An unacceptable option that psychiatrists must fight with all their strength.] 67
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors 66
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex 66
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting 65
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 63
A Critical View on New and Future Antidepressants 61
Understanding mood disorder treatments 61
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology 61
Genetic and clinical characteristics of treatment-resistant depression using primary care records in two {UK} cohorts 60
Genetic factors and symptom dimensions associated with antidepressant treatment outcomes: clues for new potential therapeutic targets? 58
Age as a moderating factor of treatment resistance in depression 58
Transdiagnostic Effects of Schizophrenia Polygenic Scores on Treatment Outcomes in Major Psychiatric Disorders 58
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics 57
Anhedonia is associated with a specific depression profile and poor antidepressant response 57
Genomics yields biological and phenotypic insights into bipolar disorder 57
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 57
Afternoon Keynote Genetic and Clinical Predictors of Antidepressant Response 55
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors 55
Antidepressant treatment in complex clinical pictures 55
Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality 54
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues 52
Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank 50
The pharmacological management of treatment-resistant depression: what does the future hold? 49
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges 49
Focus on neurodevelopmental conditions and antipsychotics prescription patterns 48
Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies 48
Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine 47
Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path 47
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments 45
Mirtazapine blood levels and antidepressant response 43
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient 42
The clinical perspective on late-onset depression in European real-world treatment settings 41
Mood disorders and somatic comorbidities 35
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis 34
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder 34
Psychological impact of neovagina creation and uterus transplantation in the patients affected from Mayer–Rokitanski–Kuster–Hauser syndrome: A narrative review 34
Modulating factors in mood disorders treatment 33
Shared genetics and causal relationship between sociability and the brain's default mode network 28
Clinical predictors of treatment resistant depression 28
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disorders 25
Telomere length and mitochondrial DNA copy number in association with trauma-focused psychotherapy efficacy 24
Polygenic scores and antidepressant treatment outcomes in major depression: a critical integrative review 24
Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer’s Disease: A Cross-sectional Study 22
The Multifaceted Etiology of Mental Disorders With a Focus on Trace Elements, a Review of Recent Literature 21
Passive suicide ideation in major depressive disorder: prognostic role and effect of antidepressant treatment 19
Schizophrenia Genetics Modulates Clinical Depressive Features 19
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe 18
Further evidence of depressive symptomatology profile predicting treatment outcome 18
Mild motor signs and depression: more than just medication side effects? 18
The Genetic Landscape of Kynurenine Predicts Neurovascular Pathology and Disrupted White Matter Integrity in Patients With Mood Disorders 17
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis 17
Oropharyngeal microbiota in patients with psychotic disorders: A scoping review on compositional and functional alterations 17
Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice 17
Moving toward precision and personalized treatment strategies in psychiatry 17
Defining and assessing international classification of disease suicidality phenotypes for genetic studies 17
Insulin resistance and poorer treatment outcomes in depression: Evidence from UK Biobank primary care data 16
The impact of depression on functioning: Relation to medication response and other predictors 15
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data 15
Unlocking the Link Between Gut Microbiota and Psychopathological Insights in Anorexia Nervosa: A Systematic Review 15
Innovations and challenges in antipsychotic treatments and external modulating factors 15
Local patterns of genetic sharing between neuropsychiatric and insulin resistance-related conditions 15
Fine-mapping genomic loci refines bipolar disorder risk genes 14
Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group 13
Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson’s disease and Lewy bodies dementia 12
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis 12
Neurological features in psychiatric disorders: biomarkers, comorbidity, and clinical translation 12
Underinvestigated aspects of depression treatment: comorbidity, quality-of-life, and novel adjuncts 12
Neuropsychiatric Symptoms and Alzheimer’s Disease Severity. A Focus on Sex-Differences 11
The genetics of treatment-resistant depression: controversies and perspectives 11
Symptom networks in major depressive disorder and treatment response: special focus on TRD 11
Differences in emotion recognition between nonimmersive versus immersive virtual reality: Preliminary findings in schizophrenia and bipolar disorder 11
Asenapine for aggressive behaviours in psychiatric disorders: a systematic review of efficacy and real-world effectiveness 10
Unsolved Issues in Anhedonia: A Call for Targeted Inquiry 10
Treatment options for depression in Parkinson's disease: a mini-review 10
New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental Pathways 9
Factors associated with drug–drug interactions involving citalopram in the UK Biobank 9
Totale 4.481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024229 0 0 0 0 0 0 0 17 30 37 80 65
2024/2025917 45 26 39 31 86 55 33 41 178 180 144 59
2025/20263.335 138 418 738 252 84 172 201 331 292 308 237 164
Totale 4.481